Huawei at MWC 2023: Intelligent World Needs Stronger ICT Industry and Digital Economy
28.2.2023 19:41:00 EET | Business Wire | Press release
During MWC Barcelona 2023, Huawei will be meeting with operators, industry partners, and other key opinion leaders from around the world to discuss "GUIDE to the Intelligent World". Together, they will look at how to use the GUIDE business blueprint to lay the foundation for 5.5G and build on the success of 5G for even greater prosperity in an intelligent world.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230228006057/en/
Huawei's Hall 1 exhibition booth at MWC Barcelona 2023 (Photo: Huawei)
Huawei’s main exhibition booth in MWC Barcelona's Hall 1 is designed around the concept of “Intelligent Future, Full of Hope”. At the booth, Huawei painted a picture of an era fueled by the digital economy and defined by collaboration that is more vibrant and full of unlimited possibilities. At the event, Huawei is also showcasing its latest products and solutions that deliver ultimate 5G experiences, premium and intelligent ultra-broadband connectivity, digital and intelligent transformation, and their Green 1-2-3 solution. Huawei's offerings show a clear commitment to innovating for the 5.5G era, creating value for customers, and stimulating the digital economy.
By the end of 2022, 5G had already proven to be a global commercial success, with over a billion mobile users connecting with 5G. Leading operators in China, South Korea, Switzerland, Finland, and Kuwait have already achieved 5G user penetration rates of more than 30%, and more than 30% of their traffic comes from 5G.
According to Ookla's latest 5G City Benchmark Report, Huawei has played an important part in 5G network construction in all of the top 10 cities among the world's 40 representative 5G-enabled cities. It's important to note that 5G performance results in these 10 cities show that the 5G networks constructed by Huawei offer the best experience.
Following on from Huawei's concept of "Striding Towards the 5.5G Era" that was proposed in July 2022, Huawei is highlighting the five major characteristics of the 5.5G era: 10 Gbps experiences, full-scenario interconnection, integrated sensing and communication, L4 autonomous driving networks, and green ICT. Leading global operators, standards organizations, and industry ecosystem partners are coming together to promote innovation and exploration for this 5.5G era, as it will create more new applications and business opportunities.
Ongoing and robust investment into ICT infrastructure directly spurs growth within the digital economy. A third-party report shows that, as new networks evolve from one generation to another, this effect will be further amplified by 15%. Looking towards the future, we believe the GUIDE business blueprint that combines both 5G and 5.5G clearly lays out how ICT evolution will progress and bring about greater value.
Together with our customers and partners, we will continue to innovate, building intelligent connectivity and redefining computing. This collaboration on innovation will create even greater value for the ICT industry and make the industry as a whole more resilient and prosperous.
Huawei’s Enterprise division is also hosting their own event at MWC 2023, themed “Leading Digital Infrastructure for New Value Together”, where they will launch more than 50 innovative products and solutions for global customers. Highlights here include their Intelligent Simplified Campus Network Solution, a series of innovative data center solutions, and business strategies for small- and medium-sized enterprises (SMEs).
In the device field, Huawei is showcasing their new HUAWEI Mate 50 series, HUAWEI WATCH Buds, HUAWEI WATCH GT Cyber, that come packed with new innovation in areas like mobile imaging, fitness and health, and smart office.
MWC Barcelona 2023 runs from February 27 to March 2 in Barcelona, Spain. Huawei showcases its products and solutions at stand 1H50 in Fira Gran Via Hall 1. Together with global operators, industry professionals, and opinion leaders, we dive into topics such as 5G business success, 5.5G opportunities, green development, digital transformation, and our vision of using the GUIDE business blueprint to lay the foundation for 5.5G and build on the success of 5G for even greater prosperity. For more information, please visit: https://carrier.huawei.com/en/events/mwc2023.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230228006057/en/
Contact information
Olivia Zhang
+86-15013066795 / +44-7444720703
zhangningning7@huawei.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 15:05:00 EEST | Press release
A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is designed to interpret cardiac MRI scans by connecting moving images of the heart with corresponding clinical radio
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 15:00:00 EEST | Press release
Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The research challenges long-held assumptions about media value, showing that not all impressions are equal. Live sports rem
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 15:00:00 EEST | Press release
Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer cell killing activity,” said David Weinreich, MD, MBA, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “The Phase 3 study and the enrollment of the first patient with Precem-TcT build on the Company’s more than 20 years of expertise in colorectal cancer, and highlight our commitment to advancing differentiated ADCs for heavily pretreated patients with limited treatment options.” The PROCEADE®-CRC-03 study
Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis21.5.2026 14:00:00 EEST | Press release
Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy's ability to improve patients' mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521877110/en/ Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis Psychotic disorders carry a massive personal burden and are associated with a lower life expectancy. Psychosis does not develop immediately, but typically emerges following a period of early, subtle symptoms. Individuals in this stage, classified as CHR-P, represent a critical pr
SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend21.5.2026 13:30:00 EEST | Press release
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and nominee brokers to submit payment instructions relating to the Company’s previously declared special cash dividend. The Company previously announced a special cash dividend of US$55.00 per common share, payable to valid holders of the Company’s common shares as of the close of business on May 23, 2025 ET. The Company previously informed shareholders that completed instruction materials were to be submitted prior to December 31, 2025 in order to facilitate receipt of the dividend. The Company has now extended that submission deadline to June 30, 2026. Shareholders and nominee brokers that have not yet submitted their instruction materials are reminded to do so on or before June 30, 2026 in order to facilitate payment of the dividend. If you have any questions regarding the process you need to un
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom